Inogen Inc — Director's Dealing 2021

Jan 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-01-15

Reporting Person: Bauerlein Alison (EVP, Finance, & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-15	Common Stock	M	18098	$16.62	Acquired	20413	Direct
2021-01-15	Common Stock	S	15966	$44.2761	Disposed	4447	Direct
2021-01-15	Common Stock	S	2132	$44.833	Disposed	2315	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-15	Stock Option (Right to Buy)	$16.62	M	18098	Disposed	2021-03-31	Common Stock (18098)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020.

F2: Represents the weighted average share price of an aggregate total of 15,966 shares sold in the price range of $43.71 to $44.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 2,132 shares sold in the price range of $44.75 to $45.215 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014.

F5: Form 4 filed on 04/02/2014 indicated an incorrect expiration date.

F6: Previously filed form 4 incorrectly listed the number of derivative securities beneficially owned as 0.